## Abstract ## Background. The purpose of this study was to study the effect of intensive targeted chemoradiation in a group of patients with head and neck cancer with stage IV inoperable disease. ## Methods. We examined 79 patients with inoperable stage IV head and neck cancer receiving intraβa
Induction intra-arterial cisplatin and bleomycin in head and neck cancer
β Scribed by Dr. Sergio Frustaci; Luigi Barzan; Giuseppe Caruso; Riccardo Ghirardo; Silva Foladore; Antonino Carbone; Yroberto Comoretto; Italo Serafini; Silvio Monfardini
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 658 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Fifty-two consecutive patients, affected by large T2 (>3 cm), T3, T4, NO, or N1 previously untreated squamous cell carcinoma of the head and neck, entered this phase 1-11 study. Treatment consisted of a continuous 8-day infusion on the following daily schedule: cisplatin 25 mg and bleomycin 15 rng administered for 4 and 20 hours, respectively. Technical-related toxicities were 1 case each of coagulation and displacement of the catheter and 1 case of reversible monoparesis of the contralateral arm. Drugrelated relevant toxicities accounted for 4 cases of grade 3 or 4 leukopenia and 2 cases of peripheral palsy of the 7th and 12th cranial nerve, respectively. Forty-five of 50 evaluable patients obtained an objective response. In particular, 13 patients obtained a complete response, 22 a partial response 275%, and 10 a partial response 250%. Furthermore, 5 of 31 patients showed a complete pathologic disappearance of the tumor, whereas in 12 of 31 only a microscopic residue was found.
π SIMILAR VOLUMES
During the 10-year period from 1966-1975, 250 patients with various head and neck cancers were treated by intra-arterial chemotherapy using single agents or various combinations. Only 15 patients showed response of I-C category according to Karnofsky's criteria, and 100 patients had I-B response. An
One hundred ninety-one patients with recurrent or metastatic squamous cell carcinoma of head and neck origin were allocated at random to chemotherapy with conventional-dose weekly intravenous methotrexate or the combination of cisplatin, vinblastine, and bleomycin. Methotrexate induced responses in